NTHI
NeOnc Technologies Holdings, Inc. Common Stock
NASDAQ: NTHI · HEALTHCARE · BIOTECHNOLOGY
$5.45
-16.02% today
Updated 2026-05-08
Market cap
$137.81M
P/E ratio
—
P/S ratio
3,446.01x
EPS (TTM)
$-3.20
Dividend yield
—
52W range
$3 – $13
Volume
0.1M
NeOnc Technologies Holdings, Inc. Common Stock (NTHI) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | $32491.00 | $728682.00 | $1.27M | $3.42M |
| Cash & equivalents | $25034.00 | $633298.00 | $31862.00 | $64893.00 |
| Current assets | $32491.00 | $728682.00 | $1.27M | $2.20M |
| Total liabilities | $2.65M | $2.30M | $15.25M | $8.92M |
| Current liabilities | $2.65M | $2.30M | $15.25M | $8.92M |
| Long-term debt | — | — | — | — |
| Shareholder equity | $-2.62M | $-1.58M | $-13.99M | $-5.50M |
| Retained earnings | $-20.74M | $-23.79M | $-38.71M | $-50.61M |
| Accounts receivable | — | — | — | $148705.00 |
| Inventory | — | — | — | — |
| Goodwill | — | — | — | — |